Journal
NEUROSCIENCE LETTERS
Volume 547, Issue -, Pages 10-15Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2013.04.057
Keywords
Alzheimer's disease; Amyloid beta; Amyloid precursor protein; Dimerization; Copper
Categories
Funding
- Research Grant Takeda science foundation [23591243]
- Grants-in-Aid for Scientific Research [23659460, 22390180, 24111524] Funding Source: KAKEN
Ask authors/readers for more resources
Alzheimer's disease (AD) is characterized by the deposition of amyloid-beta (A beta) plaques, senile plaque. The A beta peptide is cleaved from amyloid precursor protein (APP) by beta-secretase and gamma-secretase. Until now, many literatures have documented that the high concentration of copper is present in A beta plaques and enhances aggregation of. The APP copper binding domain (CuBD) is located in the N-terminal next to the growth factor-like domain that gets involved in APP homodimerization. Importantly, dimerization of APP has profound effect on A beta production. We investigated whether copper alters the state of APP dimerization and how it affects APP metabolism. Here, we demonstrate that copper enhanced APP dimerization and increased extracellular release of A beta. Moreover, copper chelator, D-penicillamine, suppressed APP dimerization and decreased extracellular release of A beta. These results suggest that the action of copper may be profoundly associated with the pathway of A beta production in AD pathogenesis. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available